The U.S. Food and Drug Administration, on Tuesday August 18, approved the first “female viagra”, Addyi to treat low sexual desire in women. Addyi (flibanserin 100 mg) (pronounced add-ee), is a once-daily, non-hormonal pill for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. “Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women”, the FDA said in a press announcement it released yesterday. “Today, we celebrate what this approval means for all women who have long awaited a medical treatment option for this life impacting condition,” said Cindy Whitehead, … Continue reading New Female Viagra to Treat Women’s Sexual Desire Disorder